In 2025, few healthcare issues have sparked as much political and public health debate as the push for OTC Ivermectin policy controversy 2025 USA in the United States. Once a relatively obscure antiparasitic drug, Ivermectin exploded into public awareness during the pandemic — fueled by social media claims about its potential benefits for Ivermectin...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek